Ikeda J, Kunimoto H, Saito Y, Tsujimoto S-I, Takeuchi M, Miura A, Kurosawa T, Murakami K, Kato I, Funakoshi-Tago M, Yokoyama A, Shiba N, Adachi S, Tomizawa D, Tamura T, Ito S, Nakajima H. Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia. haematol [Internet]. 2025Nov.1 [cited 2025Dec.5];110(11):2647-60. Available from: https://haematologica.org/article/view/12105